PTP
BMY.RT

Platform Technology Partners’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Platform Technology Partners’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$8K Sell
11,333
-950
-8% -$2.02K ﹤0.01% 242
2020
Q3 		$28K Sell
12,283
-13
-0.1% -$37 0.02% 200
2020
Q2 		$44K Sell
12,296
-1,816
-13% -$6.55K 0.03% 196
2020
Q1 		$54K Buy
14,112
+463
+3% +$1.52K 0.05% 166
2019
Q4 		$41K Buy
+13,649
New +$35.5K 0.03% 177

Other funds holding BMY.RT

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Platform Technology Partners's BMY.RT Position: Q4 2020 in Review

Platform Technology Partners reduced its Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) stake by 7.7% in Q4 2020, selling an estimated $2.02K and leaving 11,333 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #242.

Platform Technology Partners first reported a position in BMY.RT in Q4 2019 and has held it in 5 quarters since. The position peaked at $54K in Q1 2020. 546 funds tracked by Wall St. Rank hold BMY.RT as of Q4 2020.

  • Platform Technology Partners held 11,333 shares of Bristol-Myers Squibb Company Contingent Value Rights worth $8K as of Q4 2020.
  • Platform Technology Partners sold 950 Bristol-Myers Squibb Company Contingent Value Rights shares in Q4 2020, an estimated $2.02K.
  • Bristol-Myers Squibb Company Contingent Value Rights made up ﹤0.01% of Platform Technology Partners's portfolio in Q4 2020, its #242 holding.
  • Platform Technology Partners first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and has held it in 5 quarters since.
  • Platform Technology Partners's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $54K in Q1 2020.
  • 546 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q4 2020.

Based on Platform Technology Partners's 13F filing for Q4 2020, filed 9 Feb 2021.